Mazor Robotics Ltd (MZOR) 11.79 $MZOR
Global Medical Robotics Market Outlook 2015-2018
M2 - Wed Feb 11, 9:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/lz7pq9/global_medical) has announced the addition of the "Global Medical Robotics Market Outlook 2018" report to their offering. Robot-assisted radical prostatectomy is becoming the standard of care in urology, accounting for about 85% of all prostate operations in the United States. According to Intuitive Surgical, hysterectomy and other procedures, such as gallbladder removal and kidney surgery, are also driving the growth in robotic operations. According to our report, the Global Medical Robotics Market Outlook 2018, is currently worth US$ 3.2 Billion and will grow up to US$ 6.4 Billion by 2018. The report provides an overview of the total robotics market and its two main segments, which comprise Industrial Robots and Service Robots. This is followed by the present role of robotics in the healthcare industry along with the various pros and cons of integration of robotics. Segmentation of the market has been performed on the basis of the application areas as well as geographic location. The report talks about three major application areas that include Surgery, Rehabilitation, and Hospital & Laboratory. On the basis of geographic location, the market has been segmented into the US, Europe, Asia-Pacific, and the Rest of the World. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Robotics - Market Overview 4. Robotics in Healthcare 6. Drivers 7. Challenges 8. Competitive Landscape 9. Future Outlook Companies Mentioned - Accuray - Hansen Medical - Intuitive Surgical - iRobot - Stryker Corporation - Renishaw - Mazor Robotics - Stereotaxis For more information visit http://www.researchandmarkets.com/research/lz...al_medical
ISRG: 510.73 (+3.02), HNSN: 1.05 (+0.02), MZOR: 11.79 (+0.16), SYK: 94.51 (+1.14)
Mazor Robotics appoints Sandra Adzic as VP of International Sales
M2 - Thu Feb 05, 5:51AM CST
Mazor Robotics Ltd (TASE:MZOR)(NasdaqGM:MZOR), a developer of surgical guidance systems and complementary products, announced on Wednesday the appointment of Sandra Adzic as vice president of International Sales, effective immediately.
MZOR: 11.79 (+0.16)
Mazor Robotics to Report Fourth Quarter and Full Year 2014 Financial Results on February 18, 2015
Business Wire - Thu Feb 05, 3:30AM CST
Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2014, before the U.S. markets open on Wednesday, February 18, 2015.
MZOR: 11.79 (+0.16)
Mazor Robotics Names Sandra Adzic Vice President of International Sales
Business Wire - Wed Feb 04, 3:30AM CST
Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, today announced that Sandra Adzic has been named Vice President of International Sales, effective immediately. In her new position, Ms. Adzic will be responsible for creating and implementing sales strategy in Asia and Europe that will contribute to the Company's overall growth plan. Ms. Adzic will report directly to Ori Hadomi, Mazor's Chief Executive Officer.
MZOR: 11.79 (+0.16)
Mazor Robotics Announces Major Milestone in Improving the Management of Lethal Brain Cancer in Children
GlobeNewswire - Tue Feb 03, 7:10AM CST
Mazor Robotics (www.mazorrobotics.com), a global leader in the development and distribution of innovative surgical guidance systems for spine and brain surgery, announced today the first transcerebellar brainstem biopsy, performed at the University Hospital of Tubingen in Germany, using its Renaissance(R) Guidance System.
MZOR: 11.79 (+0.16)
Global Medical Robotics Market 2014-2020: Orthopedic, Neurology, Laparoscopy - Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton
M2 - Wed Jan 07, 8:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/clshb9/global_medical) has announced the addition of the "Global Medical Robotics Market by Application, Type - Segmentation and Forecast 2014-2020" report to their offering. Advances in healthcare technology over the years have showed tremendous growth. From surgical devices to radio imaging and treatment methods, all aspects of medicines have taken technological leaps in the recent decades, making healthcare technology one of the most lucrative markets. The demand for robotics in healthcare, especially surgical procedures is increasing. Robotic procedures are deemed safer in situations where humans might make errors, as robotic procedures have far greater precision and leave minimum margin for error, and therefore having robotic systems in a hospital would be able to generate more revenue. Robots can also create better clinical outcomes and curtail labour costs, leading to an exponential growth in demand. However, surgery is not the only field with robotic advancements. Robotic panels are found in all segments of healthcare, such as sanitation and for disinfecting purposes, sterilization of instruments, processing laboratory supplies and other fields where technology aids and can replace human effort. Robotics in medicine is viewed as an all-round technological advancement, which is not limited to only one section. This is potentially the biggest leap in technology for the healthcare industry since the introduction of IT and has the scope of commercially being a vibrant industry with extensive chains of supply, production and R&D development. Key Topics Covered: 1. Executive Summary 2. Healthcare robotics market overview 3. Market determinants 4. Market segmentation 5. Cost analysis 6. Market strategies 7. Market share 8. Geography analysis 9. Corporate profiles - Titan Medical Inc - Siemens Healthcare - Robotic Surgical Tech, Inc. - Medtronic, Inc. - Hitachi Medical Corp. - Hansen Medical, Inc - Ge Healthcare - Immersion Corp. - Mako Surgical Corp - Mazor Robotics Ltd For more information visit http://www.researchandmarkets.com/research/cl...al_medical
MDT: 75.26 (+0.33), HNSN: 1.05 (+0.02), IMMR: 9.01 (-0.09), MZOR: 11.79 (+0.16)
Mazor Robotics (MZOR) in Focus: Stock Falls 7.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 06, 7:30AM CST
Mazor Robotics saw a big move last session, as the company’s shares fell by over 7% on the day.
MZOR: 11.79 (+0.16), SURG: 4.44 (-0.02)
Renaissance system placements up 32% for Mazor Robotics
Seeking Alpha - at Seeking Alpha - Mon Jan 05, 6:03AM CST
MZOR: 11.79 (+0.16)
Mazor Robotics reports six orders for Renaissance systems during Q4 2014
M2 - Mon Jan 05, 5:57AM CST
Mazor Robotics Ltd (TASE:MZOR)(Nasdaq:MZOR), a developer of robotic surgical guidance systems and complementary products, today announced the receipt of six orders for its Renaissance systems in the fourth quarter ended 31 December 2014.
MZOR: 11.79 (+0.16)
Mazor Robotics Reports Orders for Six Renaissance Systems During the Fourth Quarter of 2014
Business Wire - Mon Jan 05, 3:30AM CST
Mazor Robotics Ltd. (TASE:MZOR; NASDAQ GM:MZOR), a developer of innovative guidance systems and complementary products, announced today that it received orders for and delivered six Renaissance systems, two in the U.S. and four internationally, in the fourth quarter ended December 31, 2014. The Company ended 2014 with 83 Renaissance systems globally, with 46 in the U.S., the Company's primary growth market, compared with 63 and 34 systems in 2013, respectively.
MZOR: 11.79 (+0.16)
Mazor Robotics: An Interesting Company To Put On Your Watch List
Nathan Rogers - at Seeking Alpha - Fri Dec 19, 9:25AM CST
MZOR: 11.79 (+0.16)
Mazor Robotics (MZOR) Enters Overbought Territory
Global Medical Robotics Market Outlook 2015-2018
M2 - Wed Feb 11, 9:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/lz7pq9/global_medical) has announced the addition of the "Global Medical Robotics Market Outlook 2018" report to their offering. Robot-assisted radical prostatectomy is becoming the standard of care in urology, accounting for about 85% of all prostate operations in the United States. According to Intuitive Surgical, hysterectomy and other procedures, such as gallbladder removal and kidney surgery, are also driving the growth in robotic operations. According to our report, the Global Medical Robotics Market Outlook 2018, is currently worth US$ 3.2 Billion and will grow up to US$ 6.4 Billion by 2018. The report provides an overview of the total robotics market and its two main segments, which comprise Industrial Robots and Service Robots. This is followed by the present role of robotics in the healthcare industry along with the various pros and cons of integration of robotics. Segmentation of the market has been performed on the basis of the application areas as well as geographic location. The report talks about three major application areas that include Surgery, Rehabilitation, and Hospital & Laboratory. On the basis of geographic location, the market has been segmented into the US, Europe, Asia-Pacific, and the Rest of the World. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Robotics - Market Overview 4. Robotics in Healthcare 6. Drivers 7. Challenges 8. Competitive Landscape 9. Future Outlook Companies Mentioned - Accuray - Hansen Medical - Intuitive Surgical - iRobot - Stryker Corporation - Renishaw - Mazor Robotics - Stereotaxis For more information visit http://www.researchandmarkets.com/research/lz...al_medical
ISRG: 510.73 (+3.02), HNSN: 1.05 (+0.02), MZOR: 11.79 (+0.16), SYK: 94.51 (+1.14)
Mazor Robotics appoints Sandra Adzic as VP of International Sales
M2 - Thu Feb 05, 5:51AM CST
Mazor Robotics Ltd (TASE:MZOR)(NasdaqGM:MZOR), a developer of surgical guidance systems and complementary products, announced on Wednesday the appointment of Sandra Adzic as vice president of International Sales, effective immediately.
MZOR: 11.79 (+0.16)
Mazor Robotics to Report Fourth Quarter and Full Year 2014 Financial Results on February 18, 2015
Business Wire - Thu Feb 05, 3:30AM CST
Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2014, before the U.S. markets open on Wednesday, February 18, 2015.
MZOR: 11.79 (+0.16)
Mazor Robotics Names Sandra Adzic Vice President of International Sales
Business Wire - Wed Feb 04, 3:30AM CST
Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, today announced that Sandra Adzic has been named Vice President of International Sales, effective immediately. In her new position, Ms. Adzic will be responsible for creating and implementing sales strategy in Asia and Europe that will contribute to the Company's overall growth plan. Ms. Adzic will report directly to Ori Hadomi, Mazor's Chief Executive Officer.
MZOR: 11.79 (+0.16)
Mazor Robotics Announces Major Milestone in Improving the Management of Lethal Brain Cancer in Children
GlobeNewswire - Tue Feb 03, 7:10AM CST
Mazor Robotics (www.mazorrobotics.com), a global leader in the development and distribution of innovative surgical guidance systems for spine and brain surgery, announced today the first transcerebellar brainstem biopsy, performed at the University Hospital of Tubingen in Germany, using its Renaissance(R) Guidance System.
MZOR: 11.79 (+0.16)
Global Medical Robotics Market 2014-2020: Orthopedic, Neurology, Laparoscopy - Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton
M2 - Wed Jan 07, 8:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/clshb9/global_medical) has announced the addition of the "Global Medical Robotics Market by Application, Type - Segmentation and Forecast 2014-2020" report to their offering. Advances in healthcare technology over the years have showed tremendous growth. From surgical devices to radio imaging and treatment methods, all aspects of medicines have taken technological leaps in the recent decades, making healthcare technology one of the most lucrative markets. The demand for robotics in healthcare, especially surgical procedures is increasing. Robotic procedures are deemed safer in situations where humans might make errors, as robotic procedures have far greater precision and leave minimum margin for error, and therefore having robotic systems in a hospital would be able to generate more revenue. Robots can also create better clinical outcomes and curtail labour costs, leading to an exponential growth in demand. However, surgery is not the only field with robotic advancements. Robotic panels are found in all segments of healthcare, such as sanitation and for disinfecting purposes, sterilization of instruments, processing laboratory supplies and other fields where technology aids and can replace human effort. Robotics in medicine is viewed as an all-round technological advancement, which is not limited to only one section. This is potentially the biggest leap in technology for the healthcare industry since the introduction of IT and has the scope of commercially being a vibrant industry with extensive chains of supply, production and R&D development. Key Topics Covered: 1. Executive Summary 2. Healthcare robotics market overview 3. Market determinants 4. Market segmentation 5. Cost analysis 6. Market strategies 7. Market share 8. Geography analysis 9. Corporate profiles - Titan Medical Inc - Siemens Healthcare - Robotic Surgical Tech, Inc. - Medtronic, Inc. - Hitachi Medical Corp. - Hansen Medical, Inc - Ge Healthcare - Immersion Corp. - Mako Surgical Corp - Mazor Robotics Ltd For more information visit http://www.researchandmarkets.com/research/cl...al_medical
MDT: 75.26 (+0.33), HNSN: 1.05 (+0.02), IMMR: 9.01 (-0.09), MZOR: 11.79 (+0.16)
Mazor Robotics (MZOR) in Focus: Stock Falls 7.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 06, 7:30AM CST
Mazor Robotics saw a big move last session, as the company’s shares fell by over 7% on the day.
MZOR: 11.79 (+0.16), SURG: 4.44 (-0.02)
Renaissance system placements up 32% for Mazor Robotics
Seeking Alpha - at Seeking Alpha - Mon Jan 05, 6:03AM CST
MZOR: 11.79 (+0.16)
Mazor Robotics reports six orders for Renaissance systems during Q4 2014
M2 - Mon Jan 05, 5:57AM CST
Mazor Robotics Ltd (TASE:MZOR)(Nasdaq:MZOR), a developer of robotic surgical guidance systems and complementary products, today announced the receipt of six orders for its Renaissance systems in the fourth quarter ended 31 December 2014.
MZOR: 11.79 (+0.16)
Mazor Robotics Reports Orders for Six Renaissance Systems During the Fourth Quarter of 2014
Business Wire - Mon Jan 05, 3:30AM CST
Mazor Robotics Ltd. (TASE:MZOR; NASDAQ GM:MZOR), a developer of innovative guidance systems and complementary products, announced today that it received orders for and delivered six Renaissance systems, two in the U.S. and four internationally, in the fourth quarter ended December 31, 2014. The Company ended 2014 with 83 Renaissance systems globally, with 46 in the U.S., the Company's primary growth market, compared with 63 and 34 systems in 2013, respectively.
MZOR: 11.79 (+0.16)
Mazor Robotics: An Interesting Company To Put On Your Watch List
Nathan Rogers - at Seeking Alpha - Fri Dec 19, 9:25AM CST
MZOR: 11.79 (+0.16)
Mazor Robotics (MZOR) Enters Overbought Territory
